Businesses marketing purported stem cell treatments and exosome therapies for COVID-19: An analysis of direct-to-consumer online advertising claims

We identified 38 businesses advertising purported stem cell interventions and exosome products for COVID-19. These companies operated or facilitated access to 60 clinics. More than 75% of these clinics were based in the United States and Mexico. Thirty-six of the businesses marketed their stem cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Turner, Leigh, Martinez, Juan Ramon, Najjar, Shemms, Rajapaksha Arachchilage, Thevin, Wang, Jia Chieng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Forum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679647/
https://www.ncbi.nlm.nih.gov/pubmed/37890484
http://dx.doi.org/10.1016/j.stemcr.2023.09.015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679647/
https://www.ncbi.nlm.nih.gov/pubmed/37890484
http://dx.doi.org/10.1016/j.stemcr.2023.09.015

Ejemplares similares